Hospital
Walter Knox Memorial Hospital
Walter Knox Memorial Hospital was paid $2.03M by Medicaid between Jan 2018 and Oct 2024, across 56 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoWALTER KNOX MEMORIAL HOSPITAL
EMMETT, ID 83617
EMMETT, ID 83617
33aNPI1063419018assigned 07/06/2005
33bProvider typeCritical Access Hospital
28Total paid$2.03M
24GClaims34,256
24DCodes billed56
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Critical Access Hospital providers in Idaho
Rank by total paid#3 of 20
Median peer was paid$348K
This provider vs. median5.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,524 | $761K | |
| 2019 | 10,726 | $681K | |
| 2020 | 6,169 | $395K | |
| 2021 | 2,097 | $71K | |
| 2022 | 1,952 | $58K | |
| 2023 | 1,922 | $42K | |
| 2024incomplete | 866 | $20K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 3,257 | 2,596 | $612K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 4,782 | 4,425 | $535K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 788 | 571 | $217K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.4% | 1,032 | 973 | $151K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.3% | 832 | 645 | $107K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4.4% | 608 | 519 | $90K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.0% | 1,043 | 883 | $60K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.5% | 363 | 274 | $51K |
| 80053 | Comprehensive metabolic panel | 1.4% | 3,936 | 3,266 | $27K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 296 | 292 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,740 | 3,077 | $19K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 134 | 132 | $19K |
44 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,426 | $19K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 54 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 89 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,937 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 540 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 468 | $6K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 167 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 338 | $6K |
| 84484 | <1% | 1,065 | $5K | |
| 81001 | <1% | 1,529 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 511 | $4K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 27 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $3K |
| 83690 | <1% | 417 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 469 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 29 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 457 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 26 | $2K |
| 80061 | Lipid panel | <1% | 223 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 154 | $1K |
| 87077 | <1% | 171 | $1K | |
| 87186 | <1% | 156 | $1K | |
| 81025 | <1% | 115 | $932.43 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 173 | $825.98 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 177 | $793.04 |
| 83605 | <1% | 128 | $589.79 | |
| 73630 | <1% | 47 | $567.06 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $495.45 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $468.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 31 | $424.17 |
| 85027 | <1% | 66 | $266.23 | |
| 85610 | <1% | 78 | $242.97 | |
| 84439 | <1% | 25 | $232.16 | |
| 73130 | <1% | 14 | $188.72 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 13 | $182.18 |
| 73610 | <1% | 12 | $177.06 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 43 | $146.11 |
| 11721 | <1% | 13 | $142.67 | |
| J2704 | Injection, propofol, 10 mg | <1% | 13 | $126.41 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $119.04 |
| 82150 | <1% | 18 | $103.01 | |
| 85007 | <1% | 41 | $98.90 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 33 | $45.43 |
| A9270 | Non-covered item or service | 0% | 100 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTAMPFLI, PAM (CFO)
| Provider | Location | Paid |
|---|---|---|
| Walter Knox Memorial Hospital | Emmett, ID | $34K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.